Health Care: Drugs

AMAG Pharmaceuticals Inc (AMAG: NASDAQ)

$56.5 -0.79 | -1.38%
03/30/15 - 02:01 PM ET
Company Profile
Price and Volume
Recent Price 57.29
52 Week High 59.03
52 Week Low 16.49
Avg. Daily Vol. (Mil) 0.82
Beta (3 year) 1.19
Share Related Items
Mkt Cap (Mil) 1,467.54
Shares Out (Mil) 25.62
Float (Mil) 15.54
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.10
Current Ratio 1.60
LT Debt/ Equity 1.00
Total Debt / Equity 1.08
Valuation Ratios
Price Earnings 10.60
Price/Sales 11.80
Price/Book 3.19
Price/Cash Flow 9.70
Per Share Data
Earnings 5.38
Sales 4.86
Book Value 17.96
Cash Flow 5.92
Business Summary
AMAG Pharmaceuticals Inc is a specialty pharmaceutical company with a focus on maternal health, anemia and cancer supportive care. The Company markets Makena; Feraheme, Injection for Intravenous (IV) use; and MuGard, Mucoadhesive Oral Wound Rinse.
General Information
1100 Winter Street
Waltham, MA 02451
www.amagpharma.com
Industry : Drugs
Sector: Health Care
Employees: 257
CEO: William K. Heiden
Short Interest
Current Month (Mil) 7.99
Previous Month (Mil) 8.38
Short Interest Ratio (Days) 8.20
Management Effectiveness
Return on Equity 29.50
Return on Assets 9.80
Return on Investments 14.70
Profitability
Gross Margin 96.50
EBIT Margin -2.10
Profit Margin 0.00

Portfolios with AMAG

Latest AMAG Headlines from TheStreet

More Financial News for AMAG

Press Releases for AMAG

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter